What do qualitative studies show about using text-message interventions for self-management in adults with type 2 diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Text-Message Interventions for Type 2 Diabetes Self-Management: Qualitative Evidence

Qualitative studies consistently demonstrate that text-messaging interventions are highly acceptable to adults with type 2 diabetes, with patients reporting feeling supported, gaining new knowledge, and experiencing improved self-management behaviors, particularly when messages are culturally tailored and interactive.

Key Qualitative Findings on Patient Experience

Perceived Benefits and Emotional Impact

Patients describe text-messaging interventions as providing both instrumental and emotional support. Participants frequently report feeling "as though someone was worrying about their health," which addresses the isolation many experience in diabetes self-management 1. This sense of being cared for emerges as a powerful motivator for engagement, particularly among disadvantaged populations 2.

The qualitative evidence reveals three overarching themes from patient perspectives 3:

  • Use of text messaging as a health intervention: Patients appreciate the accessibility and non-intrusive nature of SMS delivery
  • Engagement with physical activity: Messages serve as effective prompts and accountability mechanisms
  • Instilling knowledge: Patients report learning new information about diabetes control and self-care strategies 1

Cultural Tailoring is Critical

The MODEL study demonstrated that culturally competent messaging dramatically improves engagement, with greater than 90% participant retention among medically underserved African American adults when patient advisory councils informed message development 2. This contrasts sharply with generic interventions that fail to resonate with diverse populations.

Cultural tailoring involves:

  • Language adaptation (not just translation but colloquial phrasing)
  • Incorporation of culturally relevant examples and food choices
  • Addressing community-specific barriers
  • Using patient input throughout message development 2

Functionality and Design Preferences

Message Characteristics That Matter

Qualitative data identifies specific functional elements patients value 4:

  • Interactivity: Two-way communication allows patients to report barriers and receive personalized feedback
  • Personalization: Messages addressing individual barriers to adherence are perceived as more relevant
  • Timing flexibility: Patients want control over when messages arrive to fit their daily routines 5
  • Simplicity: Messages must be easily understood without requiring technical sophistication 2

Engagement Patterns Over Time

Patients describe evolving needs for message frequency. Some continue wanting daily messages throughout interventions because they maintain accountability, while others prefer reducing frequency after establishing routines 6. This suggests that offering frequency choice is important to sustained engagement rather than imposing a one-size-fits-all approach.

Support Person Engagement

An important qualitative finding shows that 48% of patients chose to invite family/friends to receive diabetes support messages 7. Those who invited support persons were:

  • Slightly younger
  • More likely to be partnered
  • Had more depressive symptoms
  • Had higher healthcare utilization (more ED visits)

Patients who invited support persons cited "needing help" and "seeing benefits of engaging others," while those who declined expressed concerns about being a "burden" 7. Support persons themselves reported that texts:

  • Increased their awareness of the patient's condition
  • Created health-related dialogue
  • Improved their own health behaviors 7

Barriers and Implementation Challenges

Patient-Level Concerns

Qualitative interviews reveal specific concerns that must be addressed during enrollment 5:

  • Privacy worries: Patients need reassurance about who sends messages (computers vs. people) and data security
  • Technical limitations: Many patients require assistance with basic phone functionality, not just the intervention itself 2
  • Message overload: Some patients initially feel overwhelmed by daily messages until they establish routines

Desired Improvements

Patients and healthcare professionals identified key enhancements 1:

  • Integration with clinical care: Linking patient responses to in-person visits
  • Tailoring to knowledge level: Adjusting message complexity based on baseline diabetes knowledge
  • Actionable reminders: Specific prompts for medication, appointments, and self-monitoring
  • Educational content: Targeted information on meal planning, exercise adaptations, and medication effects 8

Healthcare Professional Perspectives

Clinicians and nurses express positive views about text-messaging interventions but identify implementation barriers 4:

  • High satisfaction with patient engagement and outcomes
  • Concerns about workflow integration
  • Need for technical support infrastructure
  • Desire for mechanisms to review patient text responses during clinical encounters

Professionals emphasize that interventions must be "easy to access, user-friendly, and address a broad range of skills from simple to difficult" to accommodate varying levels of health literacy and technical competence 2.

Equity Considerations

Qualitative evidence strongly supports text-messaging as a tool to address health disparities. Among disadvantaged populations (low income, racial/ethnic minorities, limited education), patients report 5, 1:

  • Appreciation for low-cost intervention delivery
  • Reduced transportation and time barriers compared to in-person programs
  • Increased access to diabetes education and support
  • Feeling "heard" and valued by the healthcare system

Importantly, engagement does not differ by age, gender, education, income, or health literacy when interventions are well-designed 6, suggesting text-messaging can bridge traditional access gaps.

Accountability and Motivation

A consistent qualitative theme is patients viewing text messages as accountability partners 8. Patients describe:

  • Daily check-ins creating a sense of obligation to engage in self-care
  • Reminders preventing forgetfulness about medications or monitoring
  • Feedback messages reinforcing positive behaviors
  • Goal-setting prompts encouraging incremental improvements

Some patients explicitly request monetary incentives as extrinsic motivators for sustained engagement 8, though intrinsic motivation from perceived health benefits appears more sustainable long-term.

Common Pitfalls to Avoid

Based on qualitative findings, interventions should avoid:

  • Generic, non-personalized messages that patients perceive as irrelevant
  • Lack of cultural adaptation leading to poor resonance with target populations
  • Insufficient technical support during enrollment and early use
  • Rigid message timing without patient input on preferences
  • One-way communication that doesn't allow patient responses or questions
  • Failure to address baseline technical literacy, assuming all patients can easily use smartphones

References

Related Questions

In adults with type 2 diabetes and baseline A1c >7.5%, does a 6‑month structured short‑message‑service (SMS) program delivering 1–2 personalized messages daily reduce A1c compared with usual care?
What are the diagnostic criteria for type 2 diabetes mellitus?
For a 32‑year‑old obese male with a 10‑year history of diabetes, BMI ~35 kg/m², initial HbA1c 13.8 % (now 8.4 %), microalbuminuria, positive IA‑2 autoantibody, preserved C‑peptide, and current therapy of twice‑daily insulin (Ryzodeg), metformin (Istamet), pioglitazone (Lipaglyn), and semaglutide, should I maintain this regimen, cautiously reduce insulin dose, add an SGLT2 inhibitor, or make other therapeutic adjustments?
In a 59‑year‑old man with type 2 diabetes, weight 123 kg, on U‑500 regular insulin (115 U breakfast, 115 U lunch, 50 U dinner) who received dexamethasone 10 mg 40 hours ago, dexamethasone 6 mg 16 hours ago, and will receive another 6 mg at 14:00 today, with capillary glucose consistently >200 mg/dL despite correctional short‑acting insulin, how should his insulin regimen be adjusted?
In a 59-year-old man with type 2 diabetes weighing 123 kg who is currently receiving U‑500 regular insulin (115 units at breakfast, 115 units at lunch, 50 units at dinner) and dexamethasone (10 mg administered 40 hours ago, 6 mg administered 16 hours ago, another 6 mg scheduled at 14:00 today), with recent capillary glucose values of 362 mg/dL at breakfast, 270 mg/dL at lunch, 217 mg/dL at dinner, 261 mg/dL at 22:00, and 201 mg/dL at 02:00 despite correction doses, what should the U‑500 insulin doses be for breakfast, lunch, and dinner today?
In a patient with pancreatic body cancer invading the celiac axis and multiple lymph node metastases, who is scheduled for palliative chemotherapy and has severe abdominal and back pain (numeric rating scale >5), what is the optimal pain control strategy?
What is the appropriate non‑oral morphine dosing regimen and pregabalin dosing schedule for an opioid‑naïve patient with pancreatic cancer pain and a pain score greater than five?
What is the optimal anesthetic technique for a percutaneous vertebral biopsy in a 30‑year‑old woman at 20 weeks gestation presenting with pain?
How should a 10 mg amitriptyline tablet be discontinued—should I taper by taking a half tablet?
How should I calculate the daily oral morphine dose for an opioid‑naïve patient with pancreatic cancer pain and a pain score greater than 5?
What is the recommended daily dose of parenteral morphine for an opioid‑naïve patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.